M. Pastak

Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation.

S. Ergün, D. Saban, K. Steuhl, 2017, Human gene therapy.

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype

L. Moons, M. Hickey, A. Terasmaa, 2021, Cells.

Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model

A. Terasmaa, E. Vasar, R. Reimets, 2021, Scientific Reports.

Dietary Sugar and Salt Represent Real Risk Factors for Cataract Development

K. Kaljurand, A. Sünter, E. Juronen, 2003, Ophthalmologica.

Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram Syndrome

R. Reimets, M. Plaas, M. Plaas, 2023, Frontiers in endocrinology.